- Home
- AFJK vs FBIO Comparison
AFJK vs FBIO Comparison
Compare AFJK & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFJK
- FBIO
- Stock Information
- Founded
- AFJK 2023
- FBIO 2006
- Country
- AFJK United States
- FBIO United States
- Employees
- AFJK N/A
- FBIO N/A
- Industry
- AFJK
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- AFJK
- FBIO Health Care
- Exchange
- AFJK NYSE
- FBIO Nasdaq
- Market Cap
- AFJK 68.3M
- FBIO 58.3M
- IPO Year
- AFJK 2023
- FBIO N/A
- Fundamental
- Price
- AFJK $11.17
- FBIO $1.97
- Analyst Decision
- AFJK
- FBIO Strong Buy
- Analyst Count
- AFJK 0
- FBIO 2
- Target Price
- AFJK N/A
- FBIO $21.00
- AVG Volume (30 Days)
- AFJK 4.2K
- FBIO 219.9K
- Earning Date
- AFJK 01-01-0001
- FBIO 08-12-2025
- Dividend Yield
- AFJK N/A
- FBIO N/A
- EPS Growth
- AFJK N/A
- FBIO N/A
- EPS
- AFJK 0.23
- FBIO N/A
- Revenue
- AFJK N/A
- FBIO $57,784,000.00
- Revenue This Year
- AFJK N/A
- FBIO $51.59
- Revenue Next Year
- AFJK N/A
- FBIO $44.74
- P/E Ratio
- AFJK $48.43
- FBIO N/A
- Revenue Growth
- AFJK N/A
- FBIO N/A
- 52 Week Low
- AFJK $10.24
- FBIO $1.33
- 52 Week High
- AFJK $11.25
- FBIO $2.66
- Technical
- Relative Strength Index (RSI)
- AFJK N/A
- FBIO 55.60
- Support Level
- AFJK N/A
- FBIO $1.90
- Resistance Level
- AFJK N/A
- FBIO $2.02
- Average True Range (ATR)
- AFJK 0.00
- FBIO 0.10
- MACD
- AFJK 0.00
- FBIO -0.00
- Stochastic Oscillator
- AFJK 0.00
- FBIO 72.73
About AFJK AIMEI HEALTH TECHNOLOGY CO LTD
Aimei Health Technology Co Ltd is a blank check company.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.